An interventional study of Hemospray in Rectal Bleeding, sponsored by British Columbia Cancer Agency. Status unknown at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-09-09.
Sponsored by British Columbia Cancer Agency · Not applicable, Interventional, and Treatment
Randomized trial of Argon Plasma Coagulation compared with Argon Plasma Coagulation and Hemospray in the therapy of bleeding from Radiation Proctitis
20 patients with Radiation Proctitis will be randomized to receive either Argon Plasma Coagulation therapy alone or therapy with APC followed by Hemospray administration ;the treatment in each arm is administered during a sigmoidoscopic examination
343 studies on the registry are indexed under Gastrointestinal Hemorrhage; 80 are open to participants now.
This study's planned enrollment of 20 is below the median of 86 across 214 interventional studies indexed under Gastrointestinal Hemorrhage.
Browse Gastrointestinal Hemorrhage studies →British Columbia Cancer Agency is the lead sponsor of 152 studies on the registry; 33 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
argon plasma coagulation of radiation proctitis
Other: Hemospray
treatment of radiation proctitis with argon plasma coagulator followed by application of hemospray
Other: Hemospray
hemospray is used after argon coagulation to stop bleeding
cessation of rectal bleeding
treatment of one group of patients with Radiation Proctitis with Argon Plasma Coagulator ( APC) and a second group will be treated with APC and Hemospray
Time frame: 12 months
number of treatments required to achieve cessation of rectal bleeding
Time frame: 12 months
This study is status unknown, as verified in Sep 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
British Columbia Cancer Agency →